Axogen to buy BioCircuit Technologies for $200M

Axogen to buy BioCircuit Technologies for $200M
Axogen gains on report of takeover interest
2.2BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US05463X1063
CUSIP
523251106
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
99.04
Book Value
4.78
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.63
Wall Street Target Price
53.09
EPS Estimate Current Year
0.52
EPS Estimate Next Year
0.73
EPS Estimate Current Quarter
0.1313
EPS Estimate Next Quarter
0.1339
Most Recent Quarter
-
Revenue TTM
251,174,000
Gross Profit TTM
187,264,992
EBITDA
-5,968,000
Profit Margin
-13.36%
Return On Assets TTM
-3.15%
Return On Equity TTM
-18.21%
Revenue Per Share TTM
5.071
Qtly Revenue Growth YOY
23.10%
Diluted Eps TTM
-0.63
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
84
Price Sales TTM
11.5043
Price Book MRQ
8.5607
Enterprise Value Revenue
8
Enterprise Value EBITDA
79
80.05
2.04%23.74
1.98%77.25
1.77%308.94
1.60%96.22
1.25%104.15
1.20%91.78
0.23%27.10
0.00%46.40
-2.10%42.05
-0.80%